Risks of Venous Thromboembolism After Cesarean Sections: A Meta-Analysis

Chest

Volumn 150, Issue 3, 2016, Pages 572-596

  Blondon, Marc ^a,d   Casini, Alessandro ^a   Hoppe, Kara K ^b,c   Boehlen, Françoise ^a   Righini, Marc ^a   Smith, Nicholas L ^d,e  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

DVT; meta analysis; pregnancy; pulmonary embolism

Indexed keywords

AGE; BODY MASS; CESAREAN SECTION; CONFERENCE PAPER; DISEASE ASSOCIATION; ELECTIVE SURGERY; EMERGENCY SURGERY; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURGICAL RISK; SYSTEMATIC REVIEW; VAGINAL DELIVERY; VENOUS THROMBOEMBOLISM; COMPARATIVE STUDY; EMERGENCY; FEMALE; META ANALYSIS; OBSTETRIC DELIVERY; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PULMONARY EMBOLISM; RISK; VENOUS THROMBOSIS;

CESAREAN SECTION; DELIVERY, OBSTETRIC; ELECTIVE SURGICAL PROCEDURES; EMERGENCIES; FEMALE; HUMANS; INCIDENCE; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PULMONARY EMBOLISM; RISK; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84996536243     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.05.021     Document Type: Conference Paper

References (79)

1. 1 Pomp, E.R., Lenselink, A.M., Rosendaal, F.R., Doggen, C.J., Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 6:4 (2008), 632–637.
2. 2 Wik, H.S., Jacobsen, A.F., Sandvik, L., Sandset, P.M., Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study. J Thromb Haemost 10:5 (2012), 840–847.
3. 3 Martin, J.A., Hamilton, B.E., Osterman, M.J., Births in the United States, 2013. NCHS Data Brief(175), 2014, 1–8.
4. 4 Jacobsen, A.F., Skjeldestad, F.E., Sandset, P.M., Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost 6:6 (2008), 905–912.
5. 5 Stroup, D.F., Berlin, J.A., Morton, S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:15 (2000), 2008–2012.
6. 6 Wells G, Shea B, O'Connell J, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed March 14, 2016.
7. 7 Trinquart, L., Touze, E., Pitfalls in meta-analysis of observational studies: lessons from a systematic review of the risks of stenting for intracranial atherosclerosis. Stroke 40:10 (2009), e586–e587 author reply e590.
8. 8 James, A.H., Jamison, M.G., Brancazio, L.R., Myers, E.R., Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 194:5 (2006), 1311–1315.
9. 9 Abbasi, N., Balayla, J., Laporta, D.P., Kezouh, A., Abenhaim, H.A., Trends, risk factors and mortality among women with venous thromboembolism during labour and delivery: a population-based study of 8 million births. Arch Gynecol Obstet 289:2 (2014), 275–284.
10. 10 Macklon, N.S., Greer, I.A., Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J 41:3 (1996), 83–86.
11. 11 Treffers, P.E., Huidekoper, B.L., Weenink, G.H., Kloosterman, G.J., Epidemiological observations of thrombo-embolic disease during pregnancy and in the puerperium, in 56,022 women. Int J Gynaecol Obstetrics 21:4 (1983), 327–331.
12. 12 Galanaud, J.P., Cochery-Nouvellon, E., Alonso, S., et al. Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy. J Thromb Haemost 8:4 (2010), 707–713.
13. 13 Hiltunen, L., Rautanen, A., Rasi, V., et al. An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis: a population-based nested case-control study. Thromb Res 119:4 (2007), 423–432.
14. 14 Jacobsen, A.F., Skjeldestad, F.E., Sandset, P.M., Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium—a register-based case-control study. Am J Obstet Gynecol 198:2 (2008), 233.e1–233.e7.
15. 15 Landon, M.B., Hauth, J.C., Leveno, K.J., et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 351:25 (2004), 2581–2589.
16. 16 Virkus, R.A., Lokkegaard, E., Lidegaard, O., et al. Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort. PloS One, 9(5), 2014, e96495.
17. 17 Abdul Sultan, A., Grainge, M.J., West, J., Fleming, K.M., Nelson-Piercy, C., Tata, L.J., Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England. Blood 124:18 (2014), 2872–2880.
18. 18 Blondon, M., Harrington, L.B., Righini, M., Boehlen, F., Bounameaux, H., Smith, N.L., Racial and ethnic differences in the risk of postpartum venous thromboembolism: a population-based, case-control study. J Thromb Haemost 12:12 (2014), 2002–2009.
19. 19 Colmorn, L.B., Ladelund, S., Rasmussen, S., Secher, N.J., Risk of a venous thromboembolic episode due to caesarean section and BMI: a study in northern Denmark covering 2000-2010. J Obstet Gynaecol 34:4 (2014), 313–316.
20. 20 Sultan, A.A., Tata, L.J., West, J., et al. Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom. Blood 121:19 (2013), 3953–3961.
21. 21 Danilenko-Dixon, D.R., Heit, J.A., Silverstein, M.D., et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol 184:2 (2001), 104–110.
22. 22 Kierkegaard, A., Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstet Gynecol Scand 62:3 (1983), 239–243.
23. 23 Koroukian, S.M., Relative risk of postpartum complications in the Ohio medicaid population: vaginal versus cesarean delivery. Medical Care Res Rev 61:2 (2004), 203–224.
24. 24 Lindqvist, P.G., Torsson, J., Almqvist, A., Bjorgell, O., Postpartum thromboembolism: severe events might be preventable using a new risk score model. Vasc Health Risk Manag 4:5 (2008), 1081–1087.
25. 25 Kobayashi, T., Nakabayashi, M., Ishikawa, M., et al. Pulmonary thromboembolism in obstetrics and gynecology increased by 6.5-fold over the past decade in Japan. Circ J 72:5 (2008), 753–756.
26. 26 Burrows, L.J., Meyn, L.A., Weber, A.M., Maternal morbidity associated with vaginal versus cesarean delivery. Obstet Gynecol 103:5 pt 1 (2004), 907–912.
27. 27 Chan, L.Y., Tam, W.H., Lau, T.K., Venous thromboembolism in pregnant Chinese women. Obstet Gynecol 98:3 (2001), 471–475.
28. 28 Gherman, R.B., Goodwin, T.M., Leung, B., Byrne, J.D., Hethumumi, R., Montoro, M., Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 94:5 pt 1 (1999), 730–734.
29. 29 Simpson, E.L., Lawrenson, R.A., Nightingale, A.L., Farmer, R.D.T., Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. Br J Obstet Gynaecol 108:1 (2001), 56–60.
30. 30 Won, H.S., Kim, D.Y., Yang, M.S., Lee, S.J., Shin, H.H., Park, J.B., Pregnancy-induced hypertension, but not gestational diabetes mellitus, is a risk factor for venous thromboembolism in pregnancy. Korean Circ J 41:1 (2011), 23–27.
31. 31 Lindqvist, P., Dahlback, B., Marsal, K., Thrombotic risk during pregnancy: a population study. Obstet Gynecol 94:4 (1999), 595–599.
32. 32 Liu, S., Rouleau, J., Joseph, K.S., et al. Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada. J Obstet Gynaecol Can 31:7 (2009), 611–620.
33. 33 Ghaji, N., Boulet, S.L., Tepper, N., Hooper, W.C., Trends in venous thromboembolism among pregnancy-related hospitalizations, United States, 1994-2009. Am J Obstet Gynecol 209:5 (2013), 433.e1–433.e8.
34. 34 Kane, E.V., Calderwood, C., Dobbie, R., Morris, C., Roman, E., Greer, I.A., A population-based study of venous thrombosis in pregnancy in Scotland 1980-2005. Eur J Obstet Gynecol Reprod Biol 169:2 (2013), 223–229.
35. 35 Morris, J.M., Algert, C.S., Roberts, C.L., Incidence and risk factors for pulmonary embolism in the postpartum period. J Thromb Haemost 8:5 (2010), 998–1003.
36. 36 Pallasmaa, N., Ekblad, U., Gissler, M., Severe maternal morbidity and the mode of delivery. Acta Obstet Gynecol Scand 87:6 (2008), 662–668.
37. 37 Chauleur, C., Quenet, S., Varlet, M.N., et al. Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women. Thromb Res 122:4 (2008), 478–484.
38. 38 Silver, R.M., Landon, M.B., Rouse, D.J., et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 107:6 (2006), 1226–1232.
39. 39 Burrows, R.F., Gan, E.T., Gallus, A.S., Wallace, E.M., Burrows, E.A., A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study. BJOG 108:8 (2001), 835–839.
40. 40 Cavazza, S., Rainaldi, M.P., Adduci, A., Palareti, G., Thromboprophylaxis following cesarean delivery: one site prospective pilot study to evaluate the application of a risk score model. Thromb Res 129:1 (2012), 28–31.
41. 41 Gates, S., Brocklehurst, P., Ayers, S., Bowler, U., Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin. Am J Obstet Gynecol 191:4 (2004), 1296–1303.
42. 42 Gizzo, S., Noventa, M., Anis, O., et al. Pharmacological anti-thrombotic prophylaxis after elective caesarean delivery in thrombophilia unscreened women: should maternal age have a role in decision making?. J Perinatal Med 42:3 (2014), 339–347.
43. 43 Kalro, B.N., Davidson, R.A., Owen, P., Low incidence of asymptomatic deep venous thrombosis following caesarean section: a colour Doppler study. Health Bull 57:6 (1999), 418–421.
44. 44 Larsson, C., Saltvedt, S., Wiklund, I., Andolf, E., Planned vaginal delivery versus planned caesarean section: short-term medical outcome analyzed according to intended mode of delivery. JOGC 33:8 (2011), 796–802.
45. 45 Lindqvist, P.G., Svensson, P.J., Marsal, K., Grennert, L., Luterkort, M., Dahlback, B., Activated protein C resistance (FV: Q506) and pregnancy. Thromb Haemost 81:4 (1999), 532–537.
46. 46 Salomon, O., Seligsohn, U., Steinberg, D.M., et al. The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction. Am J Obstet Gynecol 191:6 (2004), 2002–2009.
47. 47 Häger, R.M., Daltveit, A.K., Hofoss, D., et al. Complications of cesarean deliveries: rates and risk factors. Am J Obstet Gynecol 190:2 (2004), 428–434.
48. 48 Pallasmaa, N., Ekblad, U., Aitokallio-Tallberg, A., et al. Cesarean delivery in Finland: maternal complications and obstetric risk factors. Acta Obstet Gynecol Scand 89:7 (2010), 896–902.
49. 49 Chan, L.Y., Lam, K.Y., Metreweli, C., Lau, T.K., Duplex ultrasound screening for deep vein thrombosis in Chinese after cesarean section. Acta Obstet Gynecol Scand 84:4 (2005), 368–370.
50. 50 Goto, M., Yoshizato, T., Tatsumura, M., et al. Safety and efficacy of thromboprophylaxis using enoxaparin sodium after cesarean section: a multi-center study in Japan. Taiwan J Obstet Gynecol 54:3 (2015), 248–252.
51. 51 Jacobsen, A.F., Drolsum, A., Klow, N.E., Dahl, G.F., Qvigstad, E., Sandset, P.M., Deep vein thrombosis after elective cesarean section. Thromb Res 113:5 (2004), 283–288.
52. 52 Macklon, N.S., Barry, J., Greer, I.A., Duplex ultrasound screening for deep venous thrombosis in the puerperium. Br J Obstet Gynaecol 102:3 (1995), 255–256.
53. 53 Rodger, M.A., Avruch, L.I., Howley, H.E., Olivier, A., Walker, M.C., Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section. Am J Obstet Gynecol 194:2 (2006), 436–437.
54. 54 Sia, W.W., Powrie, R.O., Cooper, A.B., et al. The incidence of deep vein thrombosis in women undergoing cesarean delivery. Thromb Res 123:3 (2009), 550–555.
55. 55 Clark, P., Walker, I.D., Govan, L., Wu, O., Greer, I.A., The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol 140:2 (2008), 236–240.
56. 56 Hannah, M.E., Hannah, W.J., Hewson, S.A., Hodnett, E.D., Saigal, S., Willan, A.R., Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group. Lancet 356:9239 (2000), 1375–1383.
57. 57 Raees, M., Yasmeen, S., Jabeen, S., Utman, N., Karim, R., Maternal morbidity associated with emergency versus elective caesarean section. J Postgrad Med Instit 27:1 (2013), 55–62.
58. 58 Said, J.M., Higgins, J.R., Moses, E.K., et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol 115:1 (2010), 5–13.
59. 59 Sharma, R., Atkin, H., Mackillop, L., Paterson-Brown, S., Assessment of the mobility of mothers postpartum to identify those at greatest risk of venous thromboembolism. J Obstet Gynaecol 32:5 (2012), 461–463.
60. 60 Hill, N.C., Hill, J.G., Sargent, J.M., Taylor, C.G., Bush, P.V., Effect of low dose heparin on blood loss at caesarean section. Br Med J (Clin Res Ed) 296:6635 (1988), 1505–1506.
61. 61 Masliah-Planchon, R., Lavigne, F., Claquin, C., Papiernik, E., Systematic prevention of deep vein thrombosis with subcutaneous heparin therapy following cesarean section. Advantages and disadvantages [in French]. J Gynecol Obstet Biol Reprod (Paris) 12:1 (1983), 95–100.
62. 62 Jackson, E., Curtis, K.M., Gaffield, M.E., Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol 117:3 (2011), 691–703.
63. 63 Abdul Sultan, A., Tata, L.J., Grainge, M.J., West, J., The incidence of first venous thromboembolism in and around pregnancy using linked primary and secondary care data: a population based cohort study from England and comparative meta-analysis. PloS One, 8(7), 2013, e70310.
64. 64 Epiney, M., Boehlen, F., Boulvain, M., et al. D-dimer levels during delivery and the postpartum. J Thromb Haemost 3:2 (2005), 268–271.
65. 65 Friedman, A.M., Ananth, C.V., Lu, Y.S., D'Alton, M.E., Wright, J.D., Underuse of postcesarean thromboembolism prophylaxis. Obstet Gynecol 122:6 (2013), 1197–1204.
66. 66 Alalaf, S.K., Jawad, R.K., Muhammad, P.R., Ali, M.S., Al Tawil, N.G., Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial. BMC Pregnancy Childbirth, 15, 2015, 72.
67. 67 James, A., Committee on Practice Bulletins–Obstetrics. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol 118:3 (2011), 718–729.
68. 68 Bates, S.M., Greer, I.A., Middeldorp, S., et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:suppl 2 (2012), e691S–e736S.
69. 69 Royal College of Obstetricians and Gynecologists. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a. 2015. https://www.rcog.uk/globalassets/documents/guidelines/gtg_37a.pdf. Accessed August 2, 2016.
70. 70 Blondon, M., Perrier, A., Nendaz, M., et al. Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery. Thromb Haemost 103:1 (2010), 129–137.
71. 71 Waldman, M., Sheiner, E., Sergienko, R., Shoham-Vardi, I., Can we identify risk factors during pregnancy for thrombo-embolic events during the puerperium and later in life?. J Matern Fetal Neonatal Med 28:9 (2015), 1005–1009.
72. 72 O'Connor, D.J., Scher, L.A., Gargiulo, N.J. 3rd, Jang, J., Suggs, W.D., Lipsitz, E.C., Incidence and characteristics of venous thromboembolic disease during pregnancy and the postnatal period: a contemporary series. Ann Vasc Surg 25:1 (2011), 9–14.
73. 73 Barrett, J.F., Hannah, M.E., Hutton, E.K., et al. A randomized trial of planned cesarean or vaginal delivery for twin pregnancy. N Engl J Med 369:14 (2013), 1295–1305.
74. 74 Hutton, E.K., Hannah, M.E., Ross, S.J., et al. The Early External Cephalic Version (ECV) 2 Trial: an international multicentre randomised controlled trial of timing of ECV for breech pregnancies. BJOG 118:5 (2011), 564–577.
75. 75 Hauth, J.C., Macpherson, C., Carey, J.C., et al. Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol 188:3 (2003), 831–835.
76. 76 Murphy, D.J., Liebling, R.E., Verity, L., Swingler, R., Patel, R., Early maternal and neonatal morbidity associated with operative delivery in second stage of labour: a cohort study. Lancet 358:9289 (2001), 1203–1207.
77. 77 Ellison, J., Thomson, A.J., Conkie, J.A., McCall, F., Walker, I.D., Greer, I.A., Thromboprophylaxis following caesarean section—a comparison of the antithrombotic properties of three low molecular weight heparins—dalteparin, enoxaparin and tinzaparin. Thromb Haemost 86:6 (2001), 1374–1378.
78. 78 Rageth, J.C., Juzi, C., Grossenbacher, H., Delivery after previous cesarean: a risk evaluation. Obstet Gynecol 93:3 (1999), 332–337.
79. 79 Nielsen, T.F., Hokegard, K.H., Postoperative cesarean section morbidity: a prospective study. Am J Obstet Gynecol 146:8 (1983), 911–916.